COMMUNIQUÉS West-GlobeNewswire

Stemline Therapeutics Reports Third Quarter 2017 Financial Results
09/11/2017
NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today financial [...]
Endocyte to Present at the Jefferies 2017 London Healthcare Conference
09/11/2017
WEST LAFAYETTE, Ind., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s [...]
Cellectar Biosciences Reports Third Quarter 2017 Financial and Corporate Performance
09/11/2017
MADISON, Wis., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), an oncology-focused, clinical stage biotechnology company (the “company”), today reported financial results and corporate [...]
Mersana Announces Third Quarter 2017 Financial Results and Provides Business Updates
09/11/2017
Received FDA Clearance of IND Application for XMT-1536, a First-in-Class Dolaflexin® Antibody Drug Conjugate Targeting NaPi2b XMT-1522 Phase 1 Trial Continues Enrollment of Patients with Advanced Tumors Expressing HER2 [...]
Zomedica Pharmaceuticals Corp. Announces Third Quarter 2017 Financial Results
09/11/2017
ANN ARBOR, Mich., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V: ZOM ) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported condensed [...]
Bio-Path Holdings Reports Third Quarter 2017 Financial Results
09/11/2017
HOUSTON, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
AveXis Reports Third Quarter 2017 Financial and Operating Results
09/11/2017
– First patient has been dosed in pivotal trial of AVXS-101 for SMA Type 1 – – Conference call and webcast November 9 at 4:30 p.m. EST – CHICAGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a [...]
Major Shareholder Announcement
09/11/2017
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; November 9, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 29 of the Danish Securities Trading Act [...]
Sharecare Ranked Among Fastest Growing Companies in North America on Deloitte’s 2017 Technology Fast 500™
09/11/2017
ATLANTA, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sharecare , the digital health company that helps people manage all their health in one place, today announced it was named to Deloitte’s Technology Fast 500™, a ranking of the [...]
NANOBIOTIX : Point sur le développement global du produit NBTXR3
09/11/2017
Nanobiotix : Point sur le développement global du produit NBTXR3 Deux présentations d'Immuno-oncologie lors de la conférence Society for Immunotherapy of Cancer (SITC) en novembre ; Données de tolérance, de sécurité et [...]
NANOBIOTIX provides update on the global development of its lead product NBTXR3
09/11/2017
Nanobiotix provides update on the global development of its lead product NBTXR3 Nanobiotix will give two immuno-oncology presentations at the Society for Immunotherapy of Cancer (SITC) conference this month Tolerability [...]
Skyline Medical Inc. Signs Distribution Agreement to Market STREAMWAY System in Australia and New Zealand
09/11/2017
MINNEAPOLIS, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]
Cytori Reports Third Quarter 2017 Business and Financial Results
09/11/2017
SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX ) (“Cytori” or the “Company”) today announced its third quarter 2017 financial results and provided updates on its corporate activity and [...]
Aileron Therapeutics Reports Third Quarter 2017 Financial Results
09/11/2017
Company continues to advance clinical trials of lead product candidate ALRN-6924 in PTCL and AML/MDS Two abstracts selected for oral presentations at American Society of Hematology Annual Meeting, highlighting potential [...]
Alphatec Holdings, Inc. Reports Third Quarter 2017 Financial Results
09/11/2017
Significant progress with transition to dedicated sales organization Continued improvement in operating expense and cash burn management CARLSBAD, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ [...]
Caladrius Biosciences Reports 2017 Third Quarter Results
09/11/2017
BASKING RIDGE, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update
09/11/2017
Announces Appointments of Michael Pehl as President and Chief Executive Officer and Brendan Delaney as Chief Commercial Officer Late-breaker Abstract on Updated Phase 2 Results of IMMU-132 in Patients with mTNBC [...]
Organovo Announces Fiscal Second-Quarter 2018 Results; Company Shifts Commercial Focus to Higher-Value Disease Modeling Opportunities and Updates Full-Year Fiscal 2018 Outlook
09/11/2017
SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today reported financial results for the fiscal second quarter of 2018 and updated its full-year fiscal 2018 outlook. The [...]
Immunomedics Appoints Michael Pehl President and Chief Executive Officer to Lead Next Phase of Transformative Growth
09/11/2017
MORRIS PLAINS, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that its Board of Directors has voted to appoint Michael Pehl as President [...]

Pages